Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Robert Ancuceanu, Theo Vos et al.|The Lancet Public Health|2025Cited by 186
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Mohammed Z. Allouh, Olugbenga Olusola Abiodun et al.|The Lancet|2025Cited by 153
The circadian clock as a potential biomarker and therapeutic target in pancreatic cancerGhazaleh Pourali, Amir Avan, Amir Mahmoud Ahmadzade et al.|Molecular and Cellular Biochemistry|2023Cited by 18
Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021Tissa Wijeratne, Yogesh Bahurupi, Jiyeon Oh et al.|Cell Reports Medicine|2025Cited by 16